FDA Approves ROXRO PHARMA’s SPRIX Nasal Spray

Options available for heroin addicts to kick the habit
  Editor’s note: The following is the third in a three-part series pertaining to the fight of law enforcement officers against drug use and distribution in Parker County, focusing on heroin. In the past year, there have been four confirmed deaths caused by heroin overdose and the number of heroin-related arrests in the county have tripled. But there is help available for lives affected by heroin.

Read more on The Weatherford Democrat

Tatum O’Neal is Redmond’s sober buddy
O’Neal is now “fully recovered” and she’s using her own experiences to set a good example to Redmond, who has spent the past few months in a drug rehabilitation facility.

Read more on KFJX Pittsburg

FDA approves ROXRO PHARMA’s SPRIX Nasal Spray
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.

Read more on News-Medical-Net

Related Drug Addiction Blogs

Subscribe to Our Feed!

Enter your email address:

Delivered by FeedBurner